Gene expression signature for classification of cancers

Details for Australian Patent Application No. 2008231393 (hide)

Owner Rosetta Genomics Ltd. Tel Hashomer Medical Infrastructure and Services Ltd.

Inventors Aharonov, Ranit; Rosenfeld, Nitzan; Barshack, Iris; Rosenwald, Shai

Agent Shelston IP

Pub. Number AU-A-2008231393

PCT Pub. Number WO2008/117278

Priority 60/907,266 27.03.07 US; 61/024,565 30.01.08 US; 60/929,244 19.06.07 US

Filing date 20 March 2008

Wipo publication date 2 October 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/117278 Priority application(s): WO2008/117278

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008231405-System and method for generating an alternating current output signal

2008231385-Delta3substituted quinoline or quinoxaline derivatives and their use as phosphatidylinositol 3-kinase ( PI3K) inhibitors